A novel study shows that marijuana users may have better blood sugar control as a result of its effect on insulin resistance.
Boston researchers report that dietary fat can affect glucose levels and insulin requirements in type 1 diabetics.
A dual-hormone artificial pancreas may have significant benefits over conventional diabetes treatment using an insulin pump.
OmniHeart Trial shows that composition of diet may be another way to up insulin sensitivity.
For participants with type 2 diabetes, correlation seen with development of CVD risk over four years.
Analysis pools results from 21 studies.
Meta-analysis shows fish oil supplements moderately increase circulating adiponectin.
Low-fat, Mediterranean, and low-carbohydrate diets are similarly effective regardless of diabetes.
In a study, South-Asian and white European diabetics showed similar declines in eGFR over five years.
Home diabetes regimen partially explains the increased risk of hypoglycemia.
New findings cast doubt on a role for surgery-related hormonal changes.
Link between CABG and reduced mortality greater for those with diabetes, tobacco use, heart failure
Canadian study of more than one million health records reveals a twofold increased risk.
Favorable changes seen in standard and novel lipoprotein and inflammatory risk factors.
HbA1c values of 6.5% or higher are associated with a nearly twofold increased risk.
Significant dose-response effect seen in normglycemic adults, with no GI side effects.
Ergocalciferol treatment of vitamin D deficiency in HD patients with type 2 diabetes is associated with a significant reduction in the risk of VAD.
More research needed to assess if this is a modifiable risk factor, researchers say.